| Full text | |
| Author(s): |
Polizel Ranieri, Ana Laura
[1]
;
Costa Pereira Jales, Sumatra Melo
[1]
;
Simoes Formigoni, Gilberto Guanaes
[2]
;
de Aloe, Flavio Sadurny
[3, 4]
;
Azevedo Tavares, Stella Marcia
[3, 4]
;
Tesseroli Siqueira, Jose Tadeu
[1]
Total Authors: 6
|
| Affiliation: | [1] Univ Sao Paulo, Sch Med, Hosp Clin, Dent Div, Cent Inst, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Med, Hosp Clin, Otorrinolaringol Dept, Sao Paulo - Brazil
[3] Univ Sao Paulo, Sch Med, Hosp Clin, Ctr Sleep Wake Disorders, Sao Paulo - Brazil
[4] Univ Sao Paulo, Inst Psychiat, Ctr Sleep Wake Disorders, Sao Paulo - Brazil
Total Affiliations: 4
|
| Document type: | Journal article |
| Source: | Sleep and Breathing; v. 13, n. 2, p. 121-125, MAY 2009. |
| Web of Science Citations: | 1 |
| Abstract | |
The aim of this study was to evaluate the efficacy of a cost-effective intra-oral appliance for obstructive sleep apnea syndrome built into a large teaching hospital. Out of 20 evaluated and treated patients, 14 concluded the study: eight men and six women, with a mean age of 42-46 (mean + SD) years and mean body mass index of 27.66. Inclusion criteria were mild or moderate apnea-hypopnea index (AHI) according to a polysomnographic study. All patients were treated with the monobloco intra-oral appliance. They were then submitted to a follow-up polysomnographic study after 60 days using the appliance. An orofacial clinical evaluation was carried out with the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) questionnaire and with clinical evaluation questionnaire devised by the Orofacial Pain Team before and 60 days after fitting the intra-oral appliance. The AHI showed a statistically meaningful (p = 0.002) reduction from 15.53 to 7.82 events per hour, a non-statistically significant oxygen saturation increase from 83.36 to 84.86 (p = 0.09), and Epworth's sleepiness scale reduction from 9.14 to 6.36 (p = 0.001). Three patients did not show any improvement. The most common side effect during the use of the appliance/device was pain and facial discomfort (28.57%), without myofascial or temporomandibular joint pain as evaluated by the RDC/TMD questionnaire. The intra-oral device produced a significant reduction of the apnea-hypopnea index during the study period with the use of the monobloco intra-oral appliance. Patients did not show prior myofascial pain or 60 days after use of the intra-oral appliance. (AU) | |
| FAPESP's process: | 07/06792-5 - Evaluation of the effectiveness of intra-oral device in the treatment of the Obstructive Sleep Apnea Syndrome in education hospital. |
| Grantee: | Ana Laura Polizel Ranieri |
| Support Opportunities: | Scholarships in Brazil - Master |